486
Can. J. Chem. Vol. 89, 2011
water (8 mL) was added dichloroacetic acid (12 mmol,
1.0 mL). The solution was cooled and kept at 0–5 8C in an
ice bath and diazotized by addition of a solution of sodium
nitrite (4.1 mmol, 0.283 g) in water (3 mL), followed by
stirring for 30 min at 0–5 8C. To a solution of the dipyrrin
(2 mmol) and triethylamine (25 mmol, 3.5 mL) in methanol
(80 mL) was slowly added a solution of the diazonium salt
at 0–5 8C. The resulting mixture was stirred for 5 h and then
evaporated under vacuum to dryness. The residues were dis-
solved in ethyl acetate and washed with water. Air was
bubbled into the organic phase for 4 h and then evaporated
and purified by column chromatography, eluting with a mix-
ture of ethyl acetate and hexane (1:20).
tion determined by NMR): C 70.40, H 4.77, N 17.28; found:
C 70.08, H 4.62, N 16.90.
Zinc complex of 1,9-di(2-isopropylphenylazo)-5-
phenyldipyrrin (5bZn)
Yield: 88%. UV–vis (1.06 Â 10–5 mol/L, CHCl3) lmax
(log 3): 367 (4.66), 615 (4.66), 674 (4.68). IR (N=N, cm–1)
1
n: 1047. H NMR (CD2Cl2) d: 7.67–7.59 (m, 10H), 7.34–
7.31 (m, 8H), 7.02 (d, 4H, J = 8.0), 6.95–6.88 (m, 8H),
6.79 (d, 4H, J = 4.5), 3.93–3.86 (m, 4H), 1.19 (s, 12H),
1.17 (s, 12H). 13C NMR (CD2Cl2) d: 167.4, 150.7, 149.0,
148.6, 142.8, 138.2, 133.9, 131.7, 131.4, 129.3, 127.7,
126.4, 126.2, 115.1, 108.4, 27.6, 23.6. ESI MS (M + H)+ m/z:
1087.8. Anal. calcd for C66H62N12ZnÁ2/3C6H14 (solvent of
crystallization determined by NMR): C 73.36, H 6.27, N
14.67; found: C 73.53, H 6.22, N 14.68.
1,9-Diphenylazo-5-(4-iodophenyl)dipyrrin (4d)
Yield: 43%; mp 164–166 8C. UV–vis (1.03 Â 10–5 mol/L,
CHCl3) lmax: 372 (4.63), 573 (4.50). IR (N=N, cm–1) n:
1
Zinc complex of 1,9-di(2-iodophenylazo)-5-phenyldipyrrin
(5cZn)
1044. H NMR (CD2Cl2) d: 8.06 (d, 4H, J = 6.8), 7.91 (d,
2H, J = 8.3), 7.64–7.57 (m, 6H), 7.35 (d, 2H, J = 8.3), 7.07
(d, 2H, J = 4.4), 6.77 (d, 2H, J = 4.4). 13C NMR (CD2Cl2) d:
163.3, 153.4, 142.7, 137.4, 135.7, 132.8, 132.1, 130.2,
129.4, 129.2, 123.4, 122.1, 115.6. ESI MS (M + H)+ m/z:
555.2. Anal. calcd for C27H19IN6Á2/5C6H14 (solvent of crys-
tallization determined by NMR): C 59.97, H 4.21, N 14.27;
found: C 60.24, H 3.78, N 14.09.
Yield: 92%. UV–vis (1.50 Â 10–5 mol/L, CHCl3) lmax
(log 3): 370 (4.69), 631 (4.80), 683 (4.83). IR (N=N, cm–1)
1
n: 1051. H NMR (CD2Cl2) d: 7.93–7.92 (dd, 2H, J = 7.0,
2.0), 7.66–7.57 (m, 10H), 7.15–7.12 (dt, 4H, J = 8.1, 1.3),
7.08–7.04 (m, 4H), 6.94–6.93 (dd, 2H, J = 6.4, 2.5), 6.91–
6.88 (q, 4H, J = 9.9), 6.76–6.75 (dd, 4H, J = 8.0, 1.4),
6.47–6.44 (dt, 4H, J = 7.9, 1.5). 13C NMR (CD2Cl2) d:
167.1, 153.0, 144.0, 140.4, 139.4, 134.8, 132.9, 131.8, 129.9,
128.3, 120.2, 117.7, 115.1, 110.4, 103.9. MALDI-TOF
MS m/z: 1421.8. Anal. calcd for C54H34I4N12ZnÁ1/2CH2Cl2
(solvents of crystallization determined by NMR): C 44.64,
H 2.41, N 11.46; found: C 44.23, H 2.63, N 11.42.
1,9-Diphenylazo-5-(2,4,6-trimethoxyphenyl)dipyrrin (4e)
Yield: 40%; mp 180–181 8C. UV–vis (1.06 Â 10–5 mol/L,
CHCl3) lmax: 351 (4.60), 573 (4.54). IR (N=N, cm–1) n:
1
1050. H NMR (CD2Cl2) d: 12.78 (b, 1H), 8.04 (d, 4H, J =
7.4), 7.59 (t, 4H, J = 7.5), 7.54 (t, 2H, J = 7.2), 6.99 (d, 2H,
J = 4.5), 6.69 (d, 2H, J = 4.4), 6.30 (s, 2H), 3.92 (s, 3H),
3.74 (s, 6H). 13C NMR (CD2Cl2) d: 162.2, 162.0, 158.9,
152.9, 143.8, 136.1, 131.2, 128.8, 128.7, 122.7, 114.8,
105.3, 90.1, 55.5, 55.0. ESI MS (M + H)+ m/z: 519.4. Anal.
calcd for C30H26N6O3Á1/5C6H14 (solvent of crystallization
determined by NMR): C 69.94, H 5.42, N 15.68; found: C
69.78, H 5.33, N 15.33.
Zinc complex of 1,9-diphenylazo-5-(4-iodophenyl)dipyrrin
(5dZn)
Yield: 85%. UV–vis (9.42 Â 10–6 mol/L, CHCl3) lmax
(log 3): 369 (4.68), 615 (4.63), 662 (4.67). IR (N=N, cm–1)
1
n: 1040. H NMR (CD2Cl2) d: 7.90 (d, 4H, J = 8.6), 7.42 (d,
8H, J = 7.1), 7.38 (t, 4H, J = 7.3), 7.29 (t, 8H, J = 7.7), 7.19
(d, 4H, J = 8.4), 6.89 (d, 4H, J = 4.6), 6.83 (d, 4H, J = 4.4).
13C NMR (CD2Cl2) d: 166.9, 154.1, 148.5, 143.2, 138.1,
137.3, 134.2, 133.4, 131.8, 129.5, 123.5, 112.6, 95.9. ESI MS
(M + H)+ m/z: 1171.1. Anal. calcd for C54H36I2N12ZnÁ4/7C6H14
(solvent of crystallization determined by NMR): C 56.47, H
3.63, N 13.76; found: C 56.01, H 3.62, N 13.38.
General procedure for the preparation of zinc complexes
of 1,9-diazodipyrrins (5Zn)
The solution of 1,9-diazodipyrrin (0.06 mmol), zinc acetyl-
acetonate hydrate (0.03 mmol, 8 mg), and triethylamine
(0.2 mmol, 28 mL) in dry dichloromethane (30 mL) was re-
fluxed for 1 h and then evaporated under vacuum to dryness.
The residue was purified by column chromatography, elut-
ing with a mixture of ethyl acetate and hexane (1:20) for
5aZn, 5dZn, and 5eZn and dichloromethane and hexane
(2:3) for 5bZn and 5cZn.
Zinc complex of 1,9-diphenylazo-5-(2,4,6-
trimethoxyphenyl)dipyrrin (5eZn)
Yield: 76%. UV–vis (CHCl3) lmax: 356, 628, 674. IR
(N=N, cm–1) n: 1048. MALDI-TOF MS (M + H)+ m/z:
1099.4.
Zinc complex of 1,9-diphenylazo-5-phenyldipyrrin (5aZn)
Yield: 90%. UV–vis (1.03 Â 10–5 mol/L, CH2Cl2) lmax
(log 3): 361 (4.64), 613 (4.61), 659 (4.67). IR (N=N, cm–1)
Preparation of the nickel complex of 1,9-diphenylazo-5-
phenyldipyrrin (5aNi)
A solution of 4a (0.06 mmol, 25.7 mg), nickel acetate tet-
rahydrate (0.03 mmol, 7.5 mg), and triethylamine
(0.2 mmol, 28 mL) in dry dichloromethane (30 mL) was re-
fluxed for 1 h and then evaporated under vacuum to dryness.
The residue was purified by column chromatography, elut-
ing with a mixture of ethyl acetate and hexane (1:20) to
give the product. Yield: 92%. UV–vis (1.10 Â 10–5 mol/L,
CHCl3) lmax (log 3): 361 (4.84), 655 (4.62). IR
1
n: 1043. H NMR (CDCl3) d: 7.56 (t, 1H, J = 7.4), 7.50 (t,
2H, J = 7.5), 7.43 (dd, 6H, J = 7.6, 1.3), 7.32 (t, 2H, J =
7.2), 7.25 (t, 4H, J = 7.55), 6.83 (d, 2H, J = 4.5), 6.79 (d,
2H, J = 4.5). 13C NMR (CDCl3) d: 166.4, 153.8, 149.4,
143.2, 138.4, 133.9, 131.4, 131.0, 129.2, 129.0, 127.6,
123.3, 111.8. MALDI-TOF MS (M)+ m/z: 918. Anal. calcd
for C54H38N12ZnÁ1/2H2OÁ1/2C6H14 (solvents of crystalliza-
Published by NRC Research Press